Physiological underpinnings of irritable bowel syndrome: Neurohormonal mechanisms

Journal of Physiology

Volumn 592, Issue 14, 2014, Pages 2967-2980

  Camilleri, Michael ^a  

^a Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN; CORTICOTROPIN RELEASING FACTOR; GLUCAGON LIKE PEPTIDE 1; MELATONIN; SEROTONIN; SEROTONIN TRANSPORTER; HORMONE;

ABDOMINAL PAIN; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM FUNCTION; DIGESTION; DISEASE ASSOCIATION; ENTEROENDOCRINE CELL; GASTROINTESTINAL TRACT FUNCTION; HORMONAL REGULATION; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; IMMUNITY; IMMUNOCOMPETENT CELL; INTESTINE ABSORPTION; INTESTINE CELL; INTESTINE FLORA; INTESTINE FUNCTION; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; MICROBIOME; NEUROENDOCRINE SYSTEM; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTOCOLONIC INHIBITION; VISCERAL AFFERENT; ANIMAL; GASTROINTESTINAL TRACT; INNERVATION; INTESTINE INNERVATION; PHYSIOLOGY;

ANIMALS; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL TRACT; HORMONES; HUMANS; IRRITABLE BOWEL SYNDROME; SEROTONIN;

EID: 84904338251     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2014.270892     Document Type: Article

References (106)

1. Aerssens J, Camilleri M, Talloen W, Thielemans L, Göhlmann HW, van den Wyngaert I, Thielemans T, De Hoogt R, Andrews CN, Bharucha AE, Carlson PJ, Busciglio I, Burton DD, Smyrk T, Urrutia R & Coulie B (2008). Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 6, 194-205.
2. Aggarwal A, Cutts TF, Abell TL, Cardoso S, Familoni B, Bremer J & Karas J (1994). Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterology 106, 945-950.
3. Alemi F, Poole DP, Chiu J, Schoonjans K, Cattaruzza F, Grider JR, Bunnett NW & Corvera CU (2013). The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice. Gastroenterology 144, 145-154.
4. Atkinson W, Lockhart S, Whorwell PJ, Keevil B & Houghton LA (2006). Altered 5-hydroxytryptamine signalling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology 130, 34-43.
5. Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J & Spiller RC (2007). Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 19 (Suppl. 1), 62-88.
6. Bampton PA, Dinning PG, Kennedy ML, Lubowski DZ & Cook IJ (2002). The proximal colonic motor response to rectal mechanical and chemical stimulation. Am J Physiol Gastrointest Liver Physiol 282, G443-G449.
7. Bellini M, Rappelli L, Blandizzi C, Costa F, Stasi C, Colucci R, Giannaccini G, Marazziti D, Betti L, Baroni S, Mumolo MG, Marchi S & Del Tacca M (2003). Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron. Am J Gastroenterol 98, 2705-2711.
8. Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, Deng Y, Blennerhassett PA, Fahnestock M, Moine D, Berger B, Huizinga JD, Kunze W, McLean PG, Bergonzelli GE, Collins SM & Verdu EF (2011). The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 23, 1132-1139.
9. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J & Cryan JF (2011). Ingestion of Lactobacillus strain regulates emotional behaviour and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108, 16050-16055.
10. Bucinskaite V, Tolessa T, Pedersen J, Rydqvist B, Zerihun L, Holst JJ & Hellström PM (2009). Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat. Neurogastroenterol Motil 21, 978-e78.
11. Burr RL, Jarrett ME, Cain KC, Jun SE & Heitkemper MM (2009). Catecholamine and cortisol levels during sleep in women with irritable bowel syndrome. Neurogastroenterol Motil 21, 1148-e97.
12. Camilleri M (2012). Peripheral mechanisms in irritable bowel syndrome. N Engl J Med 367, 1626-1635.
13. Camilleri M (2013). Pharmacological agents currently in clinical trials for disorders in neurogastroenterology. J Clin Invest 123, 4111-4120.
14. Camilleri M, Andrews CN, Bharucha AE, Carlson PJ, Ferber I, Stephens D, Smyrk TC, Urrutia R, Aerssens J, Thielemans L, Göhlmann H, van den Wyngaert I & Coulie B (2007). Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology 132, 17-25.
15. Camilleri M, Lasch K & Zhou W (2012). Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 303, G775-G785.
16. Camilleri M, McKinzie S, Busciglio I, Low PA, Sweetser S, Burton D, Baxter K, Ryks M & Zinsmeister AR (2008). Prospective study of motor, sensory, psychological and autonomic functions in 119 patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 6, 772-781.
17. Camilleri M, Vazquez-Roque M, Iturrino J, Boldingh A, Burton D, McKinzie S, Wong BS, Rao AS, Kenny E, Månsson M & Zinsmeister AR (2012). Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 303, G120-G128.
18. Chadwick VS, Gaginella TS, Carlson GL, Debongnie JC, Phillips SF & Hofmann AF (1979). Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon. J Lab Clin Med 94, 661-674.
19. Chang L, Sundaresh S, Elliott J, Anton PA, Baldi P, Licudine A, Mayer M, Vuong T, Hirano M, Naliboff BD, Ameen VZ & Mayer EA (2009). Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil 21, 149-159.
20. Cheng P, Shih W, Alberto M, Presson AP, Licudine A, Mayer EA, Naliboff BD & Chang L (2013). Autonomic response to a visceral stressor is dysregulated in irritable bowel syndrome and correlates with duration of disease. Neurogastroenterol Motil 25, e650-e659.
21. Christensen J & Rick GA (1987). Distribution of myelinated nerves in ascending nerves and myenteric plexus of cat colon. Am J Anat 178, 250-258.
22. Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe GM & Moses PL (2004). Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126, 1657-1664.
23. Costedio MM, Coates MD, Brooks EM, Glass LM, Ganguly EK, Blaszyk H, Ciolino AL, Wood MJ, Strader D, Hyman NH, Moses PL & Mawe GM (2010). Mucosal serotonin signalling is altered in chronic constipation but not in opiate-induced constipation. Am J Gastroenterol 105, 1173-1180.
24. Cryan JF & Dinan TG (2012). Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13, 701-712.
25. Dunlop SP, Coleman NS, Blackshaw E, Perkins AC, Singh G, Marsden CA & Spiller RC (2005). Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol 3, 349-357.
26. El-Salhy M (2012). Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol 18, 5151-5163.
27. El-Salhy M, Gundersen D, Hatlebakk JG, Gilja OH & Hausken T (2014). Abnormal rectal endocrine cells in patients with irritable bowel syndrome. Regul Pept 188, 60-65.
28. El-Salhy M, Lomholt-Beck B & Gundersen TD (2011). High chromogranin A cell density in the colon of patients with lymphocytic colitis. Mol Med Report 4, 603-605.
29. El-Salhy M, Wendelbo I & Gundersen D (2013). Serotonin and serotonin transporter in the rectum of patients with irritable bowel disease. Mol Med Rep 8, 451-455.
30. Elsenbruch S, Holtmann G, Oezcan D, Lysson A, Janssen O, Goebel MU & Schedlowski M (2004). Are there alterations of neuroendocrine and cellular immune responses to nutrients in women with irritable bowel syndrome? Am J Gastroenterol 99, 703-710.
31. Elsenbruch S, Lucas A, Holtmann G, Haag S, Gerken G, Riemenschneider N, Langhorst J, Kavelaars A, Heijnen CJ & Schedlowski M (2006). Public speaking stress-induced neuroendocrine responses and circulating immune cell redistribution in irritable bowel syndrome. Am J Gastroenterol 101, 2300-2307.
32. Farré R & Tack J (2013). Food and symptom generation in functional gastrointestinal disorders: physiological aspects. Am J Gastroenterol 108, 698-706.
33. FitzGerald LZ, Kehoe P & Sinha K (2009). Hypothalamic-pituitary-adrenal axis dysregulation in women with irritable bowel syndrome in response to acute physical stress. West J Nurs Res 31, 818-836.
34. Foley S, Garsed K, Singh G, Duroudier NP, Swan C, Hall IP, Zaitoun A, Bennett A, Marsden C, Holmes G, Walls A & Spiller RC (2011). Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation. Gastroenterology 140, 1434-1443.
35. Franke L, Schmidtmann M, Riedl A, van der Voort I, Uebelhack R & Mönnikes H (2010). Serotonin transporter activity and serotonin concentration in platelets of patients with irritable bowel syndrome: effect of gender. J Gastroenterol 45, 389-398.
36. Fukudo S, Nomura T & Hongo M (1998). Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 428, 45-49.
37. Fukudo S, Nomura T, Muranaka M & Taguchi F (1993). Brain-gut response to stress and cholinergic stimulation in irritable bowel syndrome. A preliminary study. J Clin Gastroenterol 17, 133-141.
38. Fukumoto S, Tatewaki M, Yamada T, Fujimiya M, Mantyh C, Voss M, Eubanks S, Harris M, Pappas TN & Takahashi T (2003). Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. Am J Physiol Regul Integr Comp Physiol 284, R1269-R1276.
39. Gebhart GF (2000). Pathobiology of visceral pain: molecular mechanisms and therapeutic implications. Visceral afferent contributions to the pathobiology of visceral pain. Am J Physiol Gastrointest Liver Physiol 278, G834-G838.
40. Greenwood-Van Meerveld B, Johnson AC, Cochrane S, Schulkin J & Myers DA (2005). Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats. Neurogastroenterol Motil 17, 415-422.
41. Han B (2013). Correlation between gastrointestinal hormones and anxiety-depressive states in irritable bowel syndrome. Exp Ther Med 6, 715-720.
42. Heitkemper M, Burr RL, Jarrett M, Hertig V, Lustyk MK & Bond EF (1998). Evidence for autonomic nervous system imbalance in women with irritable bowel syndrome. Dig Dis Sci 43, 2093-2098.
43. Heitkemper MM, Cain KC, Deechakawan W, Poppe A, Jun SE, Burr RL & Jarrett ME (2012). Anticipation of public speaking and sleep and the hypothalamic-pituitary-adrenal axis in women with irritable bowel syndrome. Neurogastroenterol Motil 24, 626-631.
44. Hellström PM, Näslund E, Edholm T, Schmidt PT, Kristensen J, Theodorsson E, Holst JJ & Efendic S (2008). GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome. Neurogastroenterol Motil 20, 649-659.
45. Houghton LA, Atkinson W, Lockhart S, Whorwell PJ & Keevil B (2007). Sigmoid-colonic motility in health and irritable bowel syndrome: a role for 5-hydroxytryptamine. Neurogastroenterol Motil 19, 724-731.
46. Houghton LA, Atkinson W, Whitaker RP, Whorwell PJ & Rimmer MJ (2003). Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut 52, 663-670.
47. Hubbard CS, Labus JS, Bueller J, Stains J, Suyenobu B, Dukes GE, Kelleher DL, Tillisch K, Naliboff BD & Mayer EA (2011). Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain. J Neurosci 31, 12491-12500.
48. Iovino P, Azpiroz F, Domingo E & Malagelada J (1995). The sympathetic nervous system modulates perception and reflex responses to gut distension in humans. Gastroenterology 108, 680-686.
49. Jarrett M, Heitkemper M, Czyzewski D, Zeltzer L & Shulman RJ (2012). Autonomic nervous system function in young children with functional abdominal pain or irritable bowel syndrome. J Pain 13, 477-484.
50. Kasimay O, Cakir B, Devseren E & Yegen BC (2005). Exogenous melatonin delays gastric emptying rate in rats: role of CCK2 and 5-HT3 receptors. J Physiol Pharmacol 56, 543-553.
51. Kennedy PJ, Clarke G, O'Neill A, Groeger JA, Quigley EM, Shanahan F, Cryan JF & Dinan TG (2014). Cognitive performance in irritable bowel syndrome: evidence of a stress-related impairment in visuospatial memory. Psychol Med 44, 1553-1566.
52. Kerckhoffs AP, ter Linde JJ, Akkermans LM & Samsom M (2012). SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine. Am J Physiol Gastrointest Liver Physiol 302, G1053-G1060.
53. Kerlin P, Zinsmeister A & Phillips S (1983). Motor responses to food of the ileum, proximal colon, and distal colon of healthy humans. Gastroenterology 84, 762-770.
54. Kreulen DL & Szurszewski JH (1979). Reflex pathways in the abdominal prevertebral ganglia: evidence for a colo-colonic inhibitory reflex. J Physiol 295, 21-32.
55. Kudielka BM, Buske-Kirschbaum A, Hellhammer DH & Kirschbaum C (2004). HPA axis responses to laboratory psychosocial stress in healthy elderly adults, younger adults, and children: impact of age and gender. Psychoneuroendocrinology 29, 83-98.
56. Labus JS, Dinov ID, Jiang Z, Ashe-McNalley C, Zamanyan A, Shi Y, Hong JY, Gupta A, Tillisch K, Ebrat B, Hobel S, Gutman BA, Joshi S, Thompson PM, Toga AW & Mayer EA (2014). Irritable bowel syndrome in female patients is associated with alterations in structural brain networks. Pain 155, 137-149.
57. Labus JS, Hubbard CS, Bueller J, Ebrat B, Tillisch K, Chen M, Stains J, Dukes GE, Kelleher DL, Naliboff BD, Fanselow M & Mayer EA (2013). Impaired emotional learning and involvement of the corticotropin-releasing factor signalling system in patients with irritable bowel syndrome. Gastroenterology 145, 1253-1261.
58. Larsson MB, Tillisch K, Craig AD, Engström M, Labus J, Naliboff B, Lundberg P, Ström M, Mayer EA & Walter SA (2012). Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome. Gastroenterology 142, 463-472.e3.
59. Lee CT, Chuang TY, Lu CL, Chen CY, Chang FY & Lee SD (1998). Abnormal vagal cholinergic function and psychological behaviors in irritable bowel syndrome patients: a hospital-based Oriental study. Dig Dis Sci 43, 1794-1799.
60. Lincoln JR, Crowe MA, Kamm MA, Burnstock G & Lennard-Jones JE (1990). Serotonin and 5-hydroxyindoleacetic acid are increased in the sigmoid colon in severe idiopathic constipation. Gastroenterology 98, 1219-1225.
61. Lovell RM & Ford AC (2012). Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 10, 712-721.
62. Lu WZ, Song GH, Gwee KA & Ho KY (2009). The effects of melatonin on colonic transit time in normal controls and IBS patients. Dig Dis Sci 54, 1087-1093.
63. Mantovani M, Kaster MP, Pertile R, Calixto JB, Rodrigues AL & Santos AR (2006). Mechanisms involved in the antinociception caused by melatonin in mice. J Pineal Res 41, 382-389.
64. Matheus N, Mendoza C, Iceta R, Mesonero JE & Alcalde AI (2010). Melatonin inhibits serotonin transporter activity in intestinal epithelial cells. J Pineal Res 48, 332-339.
65. Mawe GM & Hoffman JM (2013). Serotonin signalling in the gut - functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol 10, 473-486.
66. Mayer EA (2008). Clinical practice. Irritable bowel syndrome. N Engl J Med 358, 1692-1699.
67. Mayer EA & Tillisch K (2011). The brain-gut axis in abdominal pain syndromes. Ann Rev Med 62, 381-396.
68. Mazur M, Furgala A, Jablonski K, Madroszkiewicz D, Ciećko-Michalska I, Bugajski A & Thor PJ (2007). Dysfunction of the autonomic nervous system activity is responsible for gastric myoelectric disturbances in the irritable bowel syndrome patients. J Physiol Pharmacol 58, 131-139.
69. Miwa J, Echizen H, Matsueda K & Umeda N (2001). Patients with constipation-predominant irritable bowel syndrome may have elevated serotonin concentrations in colonic mucosa as compared with diarrhoea-predominant patients and subjects with normal bowel habit. Digestion 63, 188-194.
70. Mollen RMHG, Salvioli B, Camilleri M, Burton D, Kost LJ, Phillips SF & Pemberton JH (1999). The effects of biofeedback on rectal sensation and distal colonic motility in patients with disorders of rectal evacuation: evidence of an inhibitory rectocolonic reflex in humans? Am J Gastroenterol 94, 751-756.
71. Mönnikes H (2011). Quality of life in patients with irritable bowel syndrome. J Clin Gastroenterol 45 (Suppl. 1), S98-S101.
72. Mönnikes H, Schmidt BG & Tache Y (1993). Psychological stress-induced accelerated colonic transit in rats involves hypothalamic corticotrophin-releasing factor. Gastroenterology 104, 716-723.
73. Montero-Hadjadje M, Elias S, Chevalier L, Benard M, Tanguy Y, Turquier V, Galas L, Yon L, Malagon MM, Driouich A, Gasman S & Anouar Y (2009). Chromogranin A promotes peptide hormone sorting to mobile granules in constitutively and regulated secreting cells: role of conserved N- and C-terminal peptides. J Biol Chem 284, 12420-12431.
74. Morgan C, Nadelhaft I & deGroat WC (1986). The distribution within the spinal cord of visceral primary afferent axons carried by the lumbar colonic nerve of the cat. Brain Res 398, 11-17.
75. Öhman L & Simrén M (2010). Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 7, 163-173.
76. Öhman L, Stridsberg M, Isaksson S, Jerlstad P & Simrén M (2012). Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms? Am J Gastroenterol 107, 440-447.
77. Orr WC, Elsenbruch S & Harnish MJ (2000). Autonomic regulation of cardiac function during sleep in patients with irritable bowel syndrome. Am J Gastroenterol 98, 2865-2871.
78. Owens MJ & Nemeroff CB (1991). Physiology and pharmacology of corticotropin releasing factor. Pharmacol Rev 43, 425-473.
79. Pietroletti R, Bishop AE, Carlei F, Bonamico M, Lloyd RV, Wilson BS, Ceccamea A, Lezoche E, Speranza V & Polak JM (1986). Gut endocrine cell population in coeliac disease estimated by immunocytochemistry using a monoclonal antibody to chromogranin. Gut 27, 838-843.
80. Posserud I, Agerforz P, Ekman R, Bjornsson ES, Abrahamsson H & Simrén M (2004). Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut 53, 1102-1108.
81. Radwan P, Skrzydlo-Radomanska B, Radwan-Kwiatek K, Burak-Czapiuk B & Strzemecka J (2009). Is melatonin involved in the irritable bowel syndrome? J Physiol Pharmacol 60, 67-70.
82. Rhee SH, Pothoulakis C & Mayer EA (2009). Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 6, 306-314.
83. Rozengurt E (2006). Taste receptors in the gastrointestinal tract. I. Bitter taste receptors and α-gustducin in the mammalian gut. Am J Physiol Gastrointest Liver Physiol 291, G171-G177.
84. Sagami Y, Shimada Y, Tayama J, Nomura T, Satake M, Endo Y, Shoji T, Karahashi K, Hongo M & Fukudo S (2004). Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut 53, 958-964.
85. Shekhar C, Monaghan PJ, Morris J, Issa B, Whorwell PJ, Keevil B & Houghton LA (2013). Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin. Gastroenterology 145, 749-757; quiz e13-e14.
86. Smart HL & Atkinson M (1987). Abnormal vagal function in irritable bowel syndrome. Lancet 2, 475-478.
87. Spaziani R, Bayati A, Redmond K, Bajaj H, Mazzadi S, Bienenstock J, Collins SM & Kamath MV (2008). Vagal dysfunction in irritable bowel syndrome assessed by rectal distension and baroreceptor sensitivity. Neurogastroenterol Motil 20, 336-342.
88. Spiller RC (2001). Effects of serotonin on intestinal secretion and motility. Curr Opin Gastroenterol 17, 99-103.
89. Spiller RC (2003). Postinfectious irritable bowel syndrome. Gastroenterology 124, 1662-1671.
90. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M & Neal KR (2000). Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47, 804-811.
91. Stephen AM, Haddad AC & Phillips SF (1983). Passage of carbohydrate into the colon. Direct measurements in humans. Gastroenterology 85, 589-595.
92. Suárez-Hitz KA, Otto B, Bidlingmaier M, Schwizer W, Fried M & Ehlert U (2012). Altered psychobiological responsiveness in women with irritable bowel syndrome. Psychosom Med 74, 221-231.
93. Sweetser S, Camilleri M, Linker Nord SJ, Burton DD, Castenada L, Croop R, Tong G, Dockens R & Zinsmeister AR (2009). Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome? Am J Physiol Gastrointest Liver Physiol 296, G1299-G1306.
94. Tache Y, Mönnikes H, Bonaz B & Rivier J (1993). Role of CRF in stress-related alterations of gastric and colonic motor function. Ann N Y Acad Sci 697, 233-243.
95. Tayama J, Sagami Y, Shimada Y, Hongo M & Fukudo S (2007). Effect of alpha-helical CRH on quantitative electroencephalogram in patients with irritable bowel syndrome. Neurogastroenterol Motil 19, 471-483.
96. Teresa Martín M, Azpiroz F & Malagelada JR (2005). Melatonin as a modulator of the ileal brake mechanism. Scand J Gastroenterol 40, 559-563.
97. Thompson JJ, Elsenbruch S, Harnish MJ & Orr WC (2002). Autonomic functioning during REM sleep differentiates IBS symptom subgroups. Am J Gastroenterol 97, 3147-3153.
98. Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B, Guyonnet D, Legrain-Raspaud S, Trotin B, Naliboff B & Mayer EA (2013). Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 144, 1394-1401.
99. Tolessa T, Gutniak M, Holst JJ, Efendic S & Hellström PM (1998). Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: effect mediated through central or enteric nervous mechanisms. Dig Dis Sci 43, 2284-2290.
100. Treem WR, Ahsan N, Kastoff G & Hyams JS (1996). Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation. J Pediatr Gastroenterol Nutr 23, 280-286.
101. Videlock EJ, Adeyemo M, Licudine A, Hirano M, Ohning G, Mayer M, Mayer EA & Chang L (2009). Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome. Gastroenterology 137, 1954-1962.
102. Wang YM, Chang Y, Chang YY, Cheng J, Li J, Wang T, Zhang QY, Liang DC, Sun B & Wang BM (2012). Serotonin transporter gene promoter region polymorphisms and serotonin transporter expression in the colonic mucosa of irritable bowel syndrome patients. Neurogastroenterol Motil 24, 560-565.
103. Wisniewska-Jarosinska M, Chojnacki J, Konturek S, Brzozowski T, Smigielski J & Chojnacki C (2010). Evaluation of urinary 6-hydroxymelatonin sulphate excretion in women at different age with irritable bowel syndrome. J Physiol Pharmacol 61, 295-300.
104. Zhang H, Yan Y, Shi R, Lin Z, Wang M & Lin L (2008). Correlation of gut hormones with irritable bowel syndrome. Digestion 78, 72-76.
105. Zhao RH, Baig MK, Mack J, Abramson S, Woodhouse S & Wexner SD (2002). Altered serotonin immunoreactivities in the left colon of patients with colonic inertia. Colorectal Dis 4, 56-60.
106. Zhou Q & Verne GN (2011). New insights into visceral hypersensitivity - clinical implications in IBS. Nat Rev Gastroenterol Hepatol 8, 349-355.